121 related articles for article (PubMed ID: 25220748)
1. USL255 extended-release topiramate for the treatment of epilepsy.
Chung S
Expert Rev Neurother; 2014 Oct; 14(10):1127-37. PubMed ID: 25220748
[TBL] [Abstract][Full Text] [Related]
2. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
[TBL] [Abstract][Full Text] [Related]
3. Topiramate Extended Release: A Review in Epilepsy.
Hoy SM
CNS Drugs; 2016 Jun; 30(6):559-66. PubMed ID: 27224993
[TBL] [Abstract][Full Text] [Related]
4. Once-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.
Chung SS; Fakhoury TA; Hogan RE; Nagaraddi VN; Blatt I; Lawson B; Arnold S; Anders B; Clark AM; Laine D; Meadows RS; Halvorsen MB;
Epilepsia; 2014 Jul; 55(7):1077-87. PubMed ID: 24902983
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures.
Chung SS; Hogan RE; Blatt I; Lawson P B; Nguyen H; Clark AM; Anders B; Halvorsen MB;
Epilepsy Behav; 2016 Jun; 59():13-20. PubMed ID: 27084978
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of once-daily extended-release topiramate (USL255): a subgroup analysis based on the level of treatment resistance.
Hogan RE; Blatt I; Lawson B; Nagaraddi V; Fakhoury TA; Anders B; Clark AM; Laine D; Halvorsen MB; Chung SS
Epilepsy Behav; 2014 Dec; 41():136-9. PubMed ID: 25461205
[TBL] [Abstract][Full Text] [Related]
7. A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizures.
Chung SS
Ther Adv Neurol Disord; 2015 May; 8(3):131-6. PubMed ID: 25941540
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes.
Clark AM; Pellock JM; Holmay M; Anders B; Cloyd J
Epilepsy Behav; 2016 Apr; 57(Pt A):105-110. PubMed ID: 26943947
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
10. USL255 extended-release topiramate: dose-proportional pharmacokinetics and tolerability in healthy volunteers.
Clark AM; Halvorsen MB; Braun TL; Johnson KM; Cloyd JC
Epilepsia; 2014 Jul; 55(7):1069-76. PubMed ID: 24861853
[TBL] [Abstract][Full Text] [Related]
11. The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate.
Gidal BE; Clark AM; Anders B; Gilliam F
Epilepsy Res; 2017 Jan; 129():26-32. PubMed ID: 27883934
[TBL] [Abstract][Full Text] [Related]
12. Use of topiramate in childhood generalized seizure disorders.
Wheless JW
J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056
[TBL] [Abstract][Full Text] [Related]
13. Topiramate: a review of its use in childhood epilepsy.
Ormrod D; McClellan K
Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701
[TBL] [Abstract][Full Text] [Related]
14. Preliminary observations on topiramate in pediatric epilepsies.
Glauser TA
Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate.
Lambrecht LJ; Shekh-Ahmad T; Todd WM; Halvorsen MB; Bialer M
Epilepsia; 2011 Oct; 52(10):1877-83. PubMed ID: 21770925
[TBL] [Abstract][Full Text] [Related]
16. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
[TBL] [Abstract][Full Text] [Related]
17. Topiramate.
Glauser TA
Semin Pediatr Neurol; 1997 Mar; 4(1):34-42. PubMed ID: 9097365
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
20. Topiramate. Clinical profile in epilepsy.
Sachdeo RC
Clin Pharmacokinet; 1998 May; 34(5):335-46. PubMed ID: 9592618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
